Altria Group (MO)

Louisville, KY – November 5, 2025 – Turning Point Brands, Inc. (NYSE:TPB), a leading producer of smokeless tobacco, vaping products, and other consumer accessories, recently demonstrated its ongoing commitment to shareholder returns by declaring a regular quarterly dividend of $0.075 per share. This declaration, made on August 6, 2025, with

A middling earnings report sent the stock lower.

Zoom Communications is a good company, Cramer says. Still, he advises, "take a pass." Plus: Viking Therapeutics, Profrac and Altria.

Altria Group (MO) offers a high 7.48% dividend yield with a strong payment history and solid profitability, making it a candidate for income investors seeking steady returns.

As November 2025 unfolds, the financial markets are characterized by a palpable sense of cautious optimism, a sentiment largely underpinned by the continued prevalence and success of "dip-buying" strategies. Despite a backdrop of evolving economic conditions and geopolitical nuances, investors—both institutional and retail—are demonstrating a remarkable resilience, viewing

These five dividend stocks could give your portfolio a serious long-term boost.

These three reliable dividend stocks are built for dependable returns over short-term thrills.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

These companies are leaders in their industries and will likely remain so for the foreseeable future.

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Shares of tobacco company Altria (NYSE:MO) fell 7.3% in the morning session after the company reported third-quarter results where revenues missed expectations, overshadowing an in-line result for earnings per share. The company announced adjusted quarterly earnings of $1.45 per share, an increase from $1.40 per share reported in the same quarter the previous year. Despite the growth in profit, total sales fell 1.7% year on year to $5.25 billion, short of market forecasts for $5.32 billion. The stock's sharp decline suggested that investors were more concerned with the revenue shortfall than the stable earnings, signaling worries about the company's future sales performance.

Altria shares fall as smokeable and oral-tobacco sales slump; revenue dips despite in-line EPS, buyback expansion, and raised 2025 guidance.

Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Altria (MO) Q3 2025 Earnings Call Transcript

Tobacco company Altria (NYSE:MO) fell short of the market’s revenue expectations in Q3 CY2025, with sales falling 1.7% year on year to $5.25 billion. Its non-GAAP profit of $1.45 per share was in line with analysts’ consensus estimates.

Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session.

Altria has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.

Altria's Q3 2025 earnings missed EPS and revenue estimates, sending the stock lower. The tobacco giant narrowed its full-year guidance and boosted its share buyback program.

These consumer-facing businesses have the brand power to continue growing their dividends and your portfolio for the foreseeable future.

Philip Morris just raised its dividend payout and EPS guidance. But is it worth taking a drag on the tobacco stock?

Tobacco company Altria (NYSE:MO) will be reporting earnings this Thursday before market open. Here’s what investors should know.

The market remains hesitant to give the Zyn maker a higher valuation.